The Valley Desk

NCT01672879 · Interventional trial

Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH

Overall registry status Terminated

Phase 2

Conditions Liver Fibrosis Due to NASH

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov